MedTrace Logo

Artificial Intelligence and Dysplasia Detection in Inflammatory Bowel Disease (EIIDISIA Study)

NCT06281392 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2025-08-15

No results posted yet for this study

Summary

Randomized clinical study analyzing the efficacy of colonoscopy assisted by the Computer Aided Detection (CADe) system compared to virtual chromoendoscopy with Narrow Band Imaging (NBI) in the detection of colon dysplasia in patients with long-standing inflammatory bowel disease (IBD).

Conditions

  • Inflammatory Bowel Diseases
  • Dysplasia

Interventions

DEVICE

CADe system

Colonoscopy assisted by an artificial intelligence system (CADe).

DEVICE

NBI

Virtual colonoscopy assisted by NBI

Sponsors & Collaborators

  • University of Valencia

    collaborator OTHER

  • Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

    lead OTHER

Principal Investigators

  • Antonio López-Serrano, PhD · Hospital Universitari Dr. Peset, Valencia (Spain)

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-15
Primary Completion
2025-06-20
Completion
2025-11-20

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06281392 on ClinicalTrials.gov